Grey Cloak Tech (OTCQB: GRCK) is positioning itself to profit from the growing cannabinoid (“CBD”) market through its wholly owned subsidiary Eqova Life Sciences.
Articles
SeeThruEquity Updates Coverage on PotNetwork Holding, Inc. (POTN)
SeeThruEquity recently issued a company update and price target of $0.40 on shares of PotNetwork Holding, Inc.’s (OTC: POTN) stock.
Colorado Harvest Company’s Director of Retail Sales Brings Williams-Sonoma Taste, J. Crew Style and Eddie Bauer Adventure to Create World Class Cannabis Shopping Experiences
Colorado Harvest Company, a vertically integrated cannabis business with three dispensaries, hired Laurie Bosch as director of retail sales to strengthen its national brand by creating exciting and differentiated shopping experiences for cannabis enthusiasts in Colorado.
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Retains Medical Director to Advise Cannabis Research Programs
Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning reported that the company has hired Dr. M. Scott Alexander as a medical director.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTech™ Shines in Vegas Lights
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo.
India Globalization Capital, Inc. (NYSE: IGC) Launches Pharmaceutical Cannabinoid Pipeline Websites
India Globalization Capital (NYSE American: IGC) this morning announced the launching of two new websites.
Global Payout, Inc. (GOHE) Subsidiary Secures Definitive Referral Partnership Agreement with GreenRush Group, Inc.
Global Payout (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”) has entered a definitive Referral Partnership Agreement with GreenRush Group, Inc.
P.E.I. sets legal age for pot at 19, to be sold in government-owned stores and online
Legislation is expected to come into effect July 1, 2018.
Delta 9 Announces C$20.0 Million Bought Deal
DELTA 9 CANNABIS INC. (TSXV: NINE) announces that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. to purchase 7.4Million shares at $2.70 on a bought deal.
DOJA Cannabis Announces $15 Million Bought Deal Private Placement of Convertible Debenture Units
DOJA Cannabis Company Limited (CSE:DOJA) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, 15,000 units of the Company
MANITOBA INTRODUCES MEASURES TO RESPONSIBLY CONTROL RETAIL SALES OF CANNABIS
Regulations Announced to Keep Cannabis Out of the Hands of Youth, Away from Black Market: Stefanson-
SinglePoint, Inc. (SING) Inks LOI Formalizing Joint Venture with Smart Cannabis Corp. (SCNA)
SinglePoint (OTC: SING) and Smart Cannabis (OTC: SCNA) have signed a Letter of Intent (“LOI”) to formalize a joint venture relationship.
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management
One pioneering biopharmaceutical company, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), has triggered a paradigm shift in discovering potential breakthrough cannabinoid-based therapies. .-
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Featured in Visual Capitalist Company Spotlight
Among other areas of interest, Visual Capitalist provided an in-depth look into InMed’s Bioinformatics assessment tool, Biosynthesis cannabinoid manufacturing process, and drug pipeline of new cannabinoid treatments.
GW Pharma to Raise up to $258.75 Million in Underwritten Deal
GWPH announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares representing ordinary shares of GW on the NASDAQ Global Market in an underwritten U.S. public offering.-